VLA integrins in human skin were examined by indirect immunofluorescence utilizing antibodies recognizing the #IB, a2, a3, or a5 subunits. Staining of fetal, newborn, or adult skin with antibodies to FBI, a2, or a3 subunits gave essentially similar staining patterns: intense staining was associated with the basal layer of the epidermis, hair follicles, and blood vessel walls. The a5 subunit could be detected only in epidermis and the inner root sheath of hair follicles in fetal skin. In epidermis, the staining reaction for the .81 subunit was not only found in sites interfacing with the basement membrane zone, but also around the entire periphery of these cells. We speculate that these receptors might have previously unrecognized functions in cell-cell interactions or that these findings may suggest the presence of previously unrecognized ligands in the intercellular spaces of keratinocytes. Examination of nine nodular basal cell carcinomas revealed a prominent staining reaction with anti-,81 and anti-a3 antibodies at the periphery of the tumor islands. In contrast, staining of five squamous cell carcinomas revealed either the absence of integrins or altered and variable expression. Thus, matrix components and their receptors may participate in modulation of growth, development, and organization of human skin.
Introduction
Extracellular matrix plays an important role in the attachment, growth, and spreading of epithelial cells, such as keratinocytes, as well as in the regulation of differentiation and gene expression. Extracellular matrix components expressing such activities include fibronectin, laminin, and collagens (1) (2) (3) (4) . Interactions of extracellular matrix with cells are mediated, at least in part, by a group of cell surface receptor molecules belonging to the integrin superfamily (5) (6) (7) (8) . Each integrin receptor consists of two different subunits, designated a and 1 (5) (6) (7) (8) . All integrins of the fibronectin receptor/very late antigen (VLA)' family share a common FBI subunit, whereas the specificity for ligand binding is provided by the a subunit. Among these integrins, the a2 subunit facilitates specific binding ofthe receptor to collagenous ligands that include type I and IV collagens. The a3 subunit has a broad specificity, mediating the binding of several ligands that include fibronectin, laminin, and type I and IV collagens. The integrin receptor containing the a5 subunit is specific for high-affinity binding of fibronectin (7-1 1) .
The components of the basement membrane at the dermal-epidermal junction serve several functions. For example, type IV collagen, which interacts with other basement membrane components, has been suggested to serve as a preferential attachment substrate (12) and as an effective spreading agent (13) for cultured keratinocytes. Laminin, a noncollagenous glycoprotein consisting of three distinct subunits, has several domains with biological activities, including heparin binding, neurite outgrowth-stimulating activity, and high-affinity cell adhesion (4) . The latter activity may be mediated, in part, by the specific amino acid sequences RGD and YIGSR, which have been identified in human laminin A and B1 chains, respectively (14) .
The extracellular matrix of connective tissue probably participates in the cell growth and invasiveness associated with malignant cutaneous tumors (15) . For example, fibronectin, a ubiquitous noncollagenous glycoprotein, plays a role in epidermal healing by enhancing the migration of keratinocytes (13, 16) . Fibronectin has also been shown to be particularly abundant in the stroma of basal cell carcinomas (BCC) (17) (18) (19) (20) , and it has been recently proposed that the presence of fibronectin may explain the relatively benign clinical phenotype of these lesions (20) . Since the effects of fibronectin, laminin, and collagenous extracellular matrix components, all present both in normal skin and in cutaneous tumors (17, 20, 21) , are potentially mediated by receptors of the integrin family, we have utilized immunocytochemical techniques to examine the expression of receptors containing 13I, a2, a3, and a5 subunits in fetal, neonatal, and adult skin from normal human subjects, as well as in basal and squamous cell carcinomas.
Methods
Tissue specimens. Normal human skin was obtained from a 1 9-wk-old fetus, from the foreskin of newborn infants, or from adult individuals in connection with cosmetic surgical procedures or removal of various benign cutaneous lesions. BCC specimens were obtained from nine patients in the context of removal ofthe lesions by Mohs micrographic surgery. Squamous cell carcinoma specimens were similarly obtained from five lesions in four patients. All tissue specimens were snap-frozen and sectioned with a cryomicrotome (20) .
Indirect immunofluorescence. For indirect immunofluorescence, 5-yim frozen sections were rinsed with Tris-buffered saline (TBS, pH 7.6) , and preincubated for 15 min with TBS containing 1% bovine serum albumin (BSA). The samples were then exposed to primary antibody in appropriate dilutions (in TBS-BSA) overnight at 4VC. The sections were washed in TBS for 60 min with five changes, and incubated either with fluorescein isothiocyanate (FITC)-or with tetramethyl-rhodamine isothiocyanate-conjugated secondary antibodies (Miles Laboratories, Inc., Elkhart, IN). After a 60-min incubation at room temperature, the sections were washed with TBS for 60 min, rinsed with distilled water, and examined with a fluorescence microscope (Optiphot, Nikon Inc., Garden City, NY), equipped with filters for detection of FITC and tetramethyl-rhodamine isothiocyanate. Representative sections were photographed using Tri-X film (Eastman Kodak Co., Rochester, NY). In control reactions, the primary antibody was omitted or replaced with sera from nonimmunized animals. Faint uniform background only was observed in all controls (20) .
Peroxidase antiperoxidase (PAP) immunostaining. PAP detection was a slight modification of the method previously described in detail (22 Antibodies. The primary antibodies utilized in this study are indicated in Table I . Characterization of antibodies 3847 and J143 has been reported earlier (23) (24) (25) . Properties of the other antibodies are to be published elsewhere, and are briefly as follows. Antibody F17-6D7 is a mouse monoclonal antibody raised against human platelets that binds specifically to glycoprotein Ia/IIa (26) . Antibodies 13 and 16 are both IgG2a of rat origin raised against purified human fibronectin receptor. Antibody 13 recognizes both the mature and precursor forms (27) .
Staining of cultured human skin fibroblasts was used as a positive control for all antibodies utilized in this study. Distinct staining reaction of the cultured cells was noted indicating immunoreactivity ofthe antibodies.
The monoclonal antibodies were used at a final IgG concentration of 50 ug/ml. The polyclonal anti-human fibronectin receptor antiserum 3847 was used at a 1:100 dilution. Monoclonal antibodies to human type IV collagen were purchased from ICN Biochemicals (Lisle, IL).
Results and Discussion
Normal skin. To characterize the overall distribution of integrins in normal human skin, sections were first stained with monoclonal antibody 13 recognizing the extracellular domain of subunit I, the subunit common to all members ofthe VLA family of the integrin receptor superfamily. The results revealed intense staining associated with the plasma membranes ofbasal keratinocytes in fetal, newborn, and adult skin ( Fig. 1) . In fetal skin, the staining was most prominent along the plasma membranes at lateral and upper surfaces of basal cells (Fig. 1 d) . In contrast, in adult skin the staining reaction was more prominent along the basal surface of the basal cells apposing the dermal-epidermal basement membrane, although present in lower amounts also along all apical-lateral surfaces of basal cells (Fig. 1 f) . Assuming that the epitopes were not masked, these observations suggest that subunit l3, integrin receptors are less relevant to epidermal cell adhesion to the basement membrane in fetal skin, but may play an important role in the intercellular adhesion. A few distinct areas of dermis also stained positively with this antibody and some of this staining appeared to be in association with small blood vessels, glandular epithelia, or hair follicles (Fig. 1, a-c In further studies, specific monoclonal antibodies recognizing the a2, a3, or a5 integrin subunits were used for immunostaining, so as to allow comparative identification of specific integrins in human skin. First, skin specimens were stained with monoclonal antibody recognizing the a2 subunit (Fl 7-6D7). The results indicated positive staining in fetal, neonatal, and adult epidermis, primarily associated with the basal cell layer (Fig. 2, a-c) . No reaction was detected in the dermis. Staining of fetal skin with the J 143 antibody recognizing the a3 subunit revealed an immunoreaction closely resembling that obtained with the monoclonal antibody recognizing the a2 subunit (Fig. 2, d-f ). In addition, however, clearly detectable expression was noted in association with dermal capillaries (Fig. 2, e andf) . Somewhat diffuse staining reaction was occasionally noted in the most superficial layer of the epidermis (see Figs. 1, b and e, and 2 b, c, e, andf ) , when stained with antibodies to f0, a2, and a3, but this reaction was considered ~~~M~-I .e 'tS Staining with monoclonal antibody 16 recognizing the extracellular domain of the a5 subunit revealed only a faint and somewhat diffuse pattern in the fetal epidermis, while no reaction was detected in newborn and adult epidermis (Fig. 2, g-i) . In fetal skin, prominent staining with antibody 16 was noted in association with inner root sheath of the hair follicle (Fig. 2 g) , whereas antibodies recognizing a2 and a3 integrin subunits stained the outer root sheath (Fig. 2, a and d) . Thus, the cutaneous structures of human epidermis and dermis demonstrate differential expression of the integrin a subunits. In particular, a2/f1 and a3/f1 integrins were expressed in the epidermis at all three different stages of development studied, whereas a5/f1 integrin was readily detectable only in fetal skin. Consequently, the expression of a5/01 integrin may play a functional role during fetal development for high-affinity binding of fibronectin. In contrast, localization of the a2/fl, and a3/f1 inte- Figure 2 . Expression of integrin receptors containing a2 (a-c), a3 (d-f), or a5 (g-i) subunits in fetal (left), perinatal (middle), and adult (right column) human skin. Note the expression of a2 and a3 subunits in fetal, newborn, and adult skin, whereas a5 subunit is detected only in fetal skin. The expression of a2 and a3 subunits is localized in epidermis and the outer root sheath (a and d); the a5 subunit shows strong staining associated with the inner root sheath (g) of the hair follicle (arrow). Faint, yet clearly detectable staining with a3 antibody of dermal vessels can be detected (e, f) (arrowheads), although the same structures are essentially negative for staining with a2 and a5 antibodies. Bar, 100 gm.
grins juxtaposed to the basement membrane zone, which contains the ligand matrix components (see below), may provide continued stability to the epidermal-dermal interface. These observations are consistent with previous demonstrations that embryonic basement membranes contain fibronectin (29, 30) , although this glycoprotein is apparently not an intrinsic component of adult basement membranes (31) . The initial screening of the J 143 antibody as a potential tumor marker, before its relationship to the integrins was established, showed reaction against the basal layer of epidermis (32) . In addition, staining ofthe basal layer ofhuman fetal skin has been demonstrated (9, 10) using extracellular matrix receptor I (ECMR I) antibodies, which were recently shown to identify the same a3 molecule as J 143 (9) . Similar staining was noted with antibodies to ECMRII which corresponds to VLA-2 receptor (10). It should also be noted that absence of staining may also be caused by masking, denaturation, or even destruction of the epitope. These observations, however, agree with those showing the absence of functional fibronectin receptor in freshly isolated human keratinocytes, according to biological assays (33, 34) .
To examine the spatial distribution of a major basement membrane component that can be a potential ligand for a2/01 and a3/01 integrins, the same tissue specimens were stained with anti-type IV collagen antibodies. An intense linear staining pattern was noted in adult skin specimens juxtaposed to the basal keratinocytes (Fig. 1 h) . In contrast, the staining of the basement membrane zone in fetal skin was less prominent and more diffuse (Fig. 1 g) . Staining with type IV collagen antibody was also noted in association with dermal vascular structures both in fetal and adult skin. The localization of a3/131 integrins in the basal layer in the proximity of the dermal-epidermal basement membrane zone suggests that these receptors, at least in part, mediate the attachment of the basal cells to underlying basement membrane. Such binding may be mediated by laminin or type IV collagen which are integral parts of the basement membrane serving as ligands for the a3/f1# integrin. In support of this suggestion is the previous demonstration that collagen and laminin are capable of promoting the attachment of human basal keratinocytes in vitro (35) . The previously described subbasement membrane localization of fibronectin indicates that fibronectin-ligand binding may not participate in basal cell attachment to basement membrane, although the precise localization of fibronectin within the basement membrane zone is not entirely clear (4, 31) . Although polyclonal antibodies to human fibronectin receptor prominently stained the basal layer of the epidermis, it is most likely that this binding was due to the FBI subunit, because we failed to show any positive reaction with monoclonal antibodies directed to the a5 subunit.
BCC. The studies on normal human skin were extended to BCC. These cutaneous lesions have previously been shown to be rich in fibronectin, which localizes abundantly in the stroma of the lesions in the immediate proximity of basal cells of the tumor islands (17, 18) . Recent studies using immunocytochemistry and in situ hybridization have demonstrated that fibronectin in BCC is of the cellular type, and is produced by the peripheral basal cells of this tumor (20) . In addition to fibronectin, other basement membrane components, such as type IV collagen, can be shown to surround the BCC tumor island (Fig. 3, a and c) (21) . In most cases, the basement membrane, as visualized by staining with type IV collagen antibody, appeared intact (Fig. 3 a) , although occasional discontinuities were observed (Fig. 3 c) . Similar observations have also been reported previously in ultrastructural analyses (36) .
In the present study, staining of BCC with antibodies recognizing either the j3,, a2, a3, or a5 subunits of the integrin receptors revealed a selective expression in a manner resembling that of normal human epidermis. Specifically, the peripheral layer containing the basal cells demonstrated an intense intercellular staining with both the anti-#,S and anti-a3
antibodies, and the most intense staining was noted on the surface of the cells that interfaced with the stroma (Fig. 3 b) . However, antibodies to the a2 subunit reacted poorly with BCC islands. In areas demonstrating discontinuities in the basement membrane, as detected by antibodies to type IV collagen antibodies (Fig. 3 c) , the staining with anti-a3 antibodies showed less preferential staining for the basal keratinocytes located at the basement membrane-epithelial cell interface (Fig. 3 d) . Instead, more prominent suprabasal staining with a distinct intercellular reaction was noted, with staining extending rather uniformly around the perimeter of the cells. The latter type of staining pattern was also observed in fingerlike extensions of the basal cell carcinomas, which may represent sites of invasion of the tumors into adjacent normal tissue. Thus, it appears that intact basement membrane, through interactions mediated by integrins, may help to maintain regulation of the growth and invasiveness of these tumors.
Squamous cell carcinoma. For comparison, five squamous cell carcinomas were stained with the same battery of anti-integrin antibodies. In contrast, the staining pattern, using the same panel ofantibodies as in case of BCC or normal skin, was patchy and discontinuous in different parts of the tumors in four lesions (Fig. 4) . Clearly, the distribution of integrins in the squamous cell carcinoma lesions was different from BCC, and was not concentrated in the periphery. Staining of the same lesions with anti-type IV collagen antibody revealed the absence of an organized basement membrane in the periphery of the lesions, although faint, yet clearly detectable, staining with anti-type IV collagen antibodies could be detected within the lesions. Blood vessel-associated basement membranes were readily detectable (Fig. 4 a) . This internal staining of the lesions correlated with the presence of integrin receptors in the same approximate area of tissue (Fig. 4) . Thus, there was a general concordance in the spatial expression of integrin receptors and their corresponding ligands in the squamous cell carcinomas. In one of the lesions, no staining reaction with any of the antibodies recognizing the four different types of integrin subunits was detected either by indirect immunofluorescence or with the more sensitive PAP technique (not shown).
Interestingly, our results with malignant human epidermal carcinomas differ from earlier in vivo findings analyzing the effect of viral malignant transformation on avian fibrocytes (37) . In that study, integrin receptors were also found to be altered in distribution in Rous sarcoma virus-induced tumors, but their levels were increased, rather than unaltered or decreased as in the present studies of basal and squamous cell carcinomas. These differences might be due to the use of different species or tissue types, or to different pathogenetic mechanisms. Nevertheless, it is now clear, that a diversity of alterations in integrins will be found in malignancy.
Conclusions. Normal human skin predominantly expresses the a2/f1 and a3/f1 integrin receptor complexes in basal cells, with enrichment in sites interfacing with the basement membrane zone. However, integrin receptors were not restricted to the basement membrane-cell interface but were also found around the entire periphery of these cells, albeit often at reduced levels. These findings are of particular interest, since the intercellular spaces ofthese cells are not known to contain any ligands for the matrix receptors (i.e., fibronectin, laminin, or type IV collagen). We speculate that these receptors might have some previously unrecognized functions in cell-cell in- teractions of epithelial cells, or these findings may suggest the presence of previously unrecognized ligands in the intercellular spaces of basal keratinocytes. An alternative explanation is that keratinocytes abundantly express integrins on their surface, and when the appropriate ligands are present (such as type IV collagen, laminin, and fibronectin in mature, adult basement membrane), the integrins are concentrated on these sites. When keratinocyte proliferation occurs and the cells are displaced from the basal lamina, integrin expression declines and their distribution becomes diffuse. This alternative explanation is supported by previous observations (38) that suggest that integrin location on cells is profoundly affected by the ligand.
In basal cell carcinomas, localization of a3/01 integrins was demonstrated in close proximity to apparently intact basement membrane. In the areas of fragmentation and discontinuity, integrin receptors did not preferentially localize to the epithelial-mesenchymal interface, but instead a suprabasal intercellular staining pattern was observed. These areas may well represent sites of invasion by this locally destructive tumor.
In squamous cell carcinomas, a variable staining pattern was observed. Ifpresent, the integrins were not at the periphery of the tumors, and occasional intralesional expression was detected. These observations possibly reflect impaired tumormatrix interactions, and may relate to the much more malignant phenotype of squamous cell carcinomas.
